Biography
Dr. Matthew Steensma is a medical oncologist at Mayo Clinic who contributes to the multidisciplinary care of mesothelioma patients. Working within Mayo Clinic's thoracic oncology group alongside Dr. Aaron Mansfield and Dr. Dennis Wigle, he helps coordinate systemic therapy including chemotherapy, immunotherapy, and clinical trial enrollment for mesothelioma patients.
Education & Training
- Medical Degree — University of Michigan Medical School (Medicine)
- Residency — Mayo Clinic (Internal Medicine)
- Fellowship — Mayo Clinic (Medical Oncology)
Specialties & Procedures
Clinical Specialties
- Medical Oncology
- Thoracic Oncology
As a medical oncologist, Dr. Matthew Steensma focuses on non-surgical treatment modalities including chemotherapy, immunotherapy, targeted therapy, and clinical trials.
Board Certifications
- American Board of Internal Medicine — Medical Oncology
- American Board of Internal Medicine — Internal Medicine
Research Focus
Systemic therapy for mesothelioma, clinical trials for rare thoracic malignancies, and biomarker-directed treatment selection.
Treatment Center
Dr. Matthew Steensma practices at Mayo Clinic in Rochester, MN.
Legal Resources for Mesothelioma Patients
Patients diagnosed with mesothelioma after asbestos exposure may be eligible for compensation through asbestos trust funds and legal claims. Over $30 billion remains available in trust funds nationwide.
Frequently Asked Questions
How does Dr. Steensma work with the Mayo mesothelioma team?
Dr. Steensma is part of Mayo Clinic's multidisciplinary thoracic oncology group, collaborating with surgeons and radiation oncologists to develop individualized treatment plans for mesothelioma patients.